Department of Digestive Oncology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, Shanxi; Department of Digestive Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Chin J Physiol. 2023 Mar-Apr;66(2):93-102. doi: 10.4103/cjop.CJOP-D-22-00078.
Gastric cancer is a type of digestive tract cancer with a high morbidity and mortality, which leads to a major health burden worldwide. More research into the functions of the immune system will improve therapy and survival in gastric cancer patients. We attempted to identify potential biomarkers or targets in gastric cancer via bioinformatical analysis approaches. Three gene expression profile datasets (GSE79973, GSE103236, and GSE118916) of gastric tissue samples were obtained from the Gene Expression Omnibus database. There were 65 overlapping differentially expressed genes (DEGs) identified from three microarrays. Gene ontology and Kyoto Encyclopedia of Genes and Genomes pathway were carried out for the key functions and pathways enriched in the DEGs. Then, ten hub genes were identified by protein-protein interaction network. In addition, we observed that collagen type V alpha 2 (COL5A2) was linked to gastric cancer prognosis as well as M2 macrophage infiltration. Furthermore, COL5A2 enhanced gastric cancer cell proliferation through the PI3K-AKT signaling pathway and polarized M2 macrophage cells. Therefore, in this study, we found that COL5A2 was associated with the development of gastric cancer which might function as a potential therapeutic target for the disease.
胃癌是一种发病率和死亡率都很高的消化道癌症,在全球范围内给人们的健康带来了重大负担。对免疫系统功能的进一步研究将改善胃癌患者的治疗效果和生存率。我们试图通过生物信息学分析方法来确定胃癌中的潜在生物标志物或靶点。从基因表达综合数据库中获得了三个胃癌组织样本的基因表达谱数据集(GSE79973、GSE103236 和 GSE118916)。从三个微阵列中鉴定出了 65 个重叠的差异表达基因(DEGs)。对 DEGs 中富集的关键功能和途径进行了基因本体论和京都基因与基因组百科全书通路分析。然后,通过蛋白质-蛋白质相互作用网络鉴定了十个枢纽基因。此外,我们观察到,胶原类型 V alpha 2(COL5A2)与胃癌预后以及 M2 巨噬细胞浸润有关。此外,COL5A2 通过 PI3K-AKT 信号通路增强胃癌细胞的增殖并极化 M2 巨噬细胞。因此,在这项研究中,我们发现 COL5A2 与胃癌的发展有关,它可能是该疾病的一个潜在治疗靶点。